Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
Add more filters










Publication year range
1.
Lab Chip ; 14(21): 4244-9, 2014 Nov 07.
Article in English | MEDLINE | ID: mdl-25208130

ABSTRACT

Open-access optical microcavities provide a novel approach to label-free lab-on-a-chip optofluidic sensing. They offer direct access to a highly confined electromagnetic field, and yield a femtoliter detection volume. This article describes the characteristics of these devices for refractive index sensing. We show that most of the ambient noise can be removed from the refractive index data by simultaneous tracking of resonances across an array of cavities. A sensitivity of 3.5 × 10(-4) RIU is demonstrated which corresponds to detecting the refractive index change caused by the presence of 500,000 glucose molecules in aqueous solution.

4.
Neurol Res ; 26(7): 767-73, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15494120

ABSTRACT

Lectin-like oxidized low-density lipoprotein receptor (LOX-1) and monocyte chemoattractant protein-1 (MCP-1) are molecules involving in the initiation and progression of atherosclerosis. In order to examine a possible difference in LOX-1 and MCP-1 expressions depending on the severity of early stage of atherosclerosis, we investigated atherosclerotic changes by exposure to hypertension and hyperlipidemia in common carotid arteries (CCAs) of stroke-prone spontaneously hypertensive rat (SHR-SP). Three rat model groups such as control [Wistar Kyoto rat (WKY) group], hypertension (SHR-SP group) and hypertension + hyperlipidemia [SHR-SP + high fat and cholesterol (HFC) group] were used. Body weights, brain weights, systolic blood pressures and serum levels of total cholesterol, low-density lipoprotein and triglyceride were measured at 0, 5, 10 and 15 days after appropriate diet. Immunohistochemistry showed that the positive area and the strength of LOX-1 and MCP-1 were larger in the SHR-SP + HFC group than in the SHR-SP group, while no immunoreactivities were found in the WKY group. Conventional RT-PCR and real-time PCR analyses showed that mRNAs of those in the SHR-SP group were higher with greater up-regulation in the SHR-SP + HFC group. LOX-1 and MCP-1 expressions were coordinately up-regulated at mRNA and protein levels in an early stage of sclerosis depending on the severity of atherosclerotic stress. Activations of LOX-1 and MCP-1 are collectively involved in the early stage of atherosclerosis.


Subject(s)
Arteriosclerosis/metabolism , Carotid Artery, Common/metabolism , Chemokine CCL2/metabolism , Hypertension/pathology , Receptors, LDL/metabolism , Animals , Arteriosclerosis/etiology , Biomarkers/metabolism , Body Weight/physiology , Brain/physiology , Chemokine CCL2/genetics , Diet , Hypertension/genetics , Immunohistochemistry/methods , Lipids/blood , Male , Models, Cardiovascular , Organ Size , RNA, Messenger/biosynthesis , Rats , Rats, Inbred SHR , Rats, Inbred WKY , Receptors, LDL/genetics , Receptors, Oxidized LDL , Reverse Transcriptase Polymerase Chain Reaction/methods , Scavenger Receptors, Class E , Time Factors , Up-Regulation
5.
Neurol Res ; 25(5): 516-21, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12866201

ABSTRACT

Functional recovery by the application of electro-acupuncture (EA) on different acupoints was investigated using a transient middle cerebral artery occlusion (MCAO) model in rat. Acupoints were Baihui (D20) plus Renzhong (D26) (MCAO + D group), and Hanyan (G4), Xuanlu (G5), Xuanli (G6), plus Qubin (G7) (MCAP + G group). Animals with EA treatment showed significant functional improvements from 12 days after the reperfusion against those without EA treatment. Among EA treated groups, MCAO + G showed a more significant recovery than MCAO + D. Infarct volume revealed the significant reduction in the EA treated groups especially in MCAO + G at 30 days. Immunohistochemical study showed a remarkable induction of vascular endothelial growth factor (VEGF) in astrocytes of the peri-infarct area at 30 days, more in EA treated groups than in groups treated with MCAO alone. These results suggest that the acupoints applied in this study are effective for the functional recovery, and an enhanced expression of VEGF may play a certain role in recovery process after stroke.


Subject(s)
Electroacupuncture , Infarction, Middle Cerebral Artery/therapy , Ischemic Attack, Transient/therapy , Animals , Astrocytes/chemistry , Blood-Brain Barrier , Brain/blood supply , Brain/pathology , Endothelial Growth Factors/analysis , Immunohistochemistry , Infarction, Middle Cerebral Artery/pathology , Intercellular Signaling Peptides and Proteins/analysis , Ischemic Attack, Transient/pathology , Lymphokines/analysis , Male , Motor Activity , Neurologic Examination , Rats , Rats, Wistar , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
6.
Neurol Res ; 25(3): 249-53, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12739232

ABSTRACT

Neuroprotective effects of glial cell line-derived neurotrophic factor (GDNF) on cell survival and death signals were investigated after 90 min of transient middle cerebral artery occlusion (MCAO) in rats. Immunoreactivities of phosphorylated Akt (p-Akt), cleaved caspase-9 (c-cas9), and -3 (c-cas3) increased after the reperfusion in the penumbra in vehicle group with peaks at 3 h, 8 h, and 1 day, respectively. Topical application of GDNF (6.8 micrograms/9 microliters) on brain surface potentiated and prolonged p-Akt activation, but suppressed activation of the caspases, and reduced the number of terminal deoxynucleotidyl transferase-mediated dUDP-biotin in situ nick labeling (TUNEL) positive cells. These results suggest that GDNF plays a protective role against ischemic injury by controlling the balance between Akt pathway and caspase cascades.


Subject(s)
Brain Ischemia/drug therapy , Nerve Growth Factors/therapeutic use , Neuroprotective Agents/therapeutic use , Protein Serine-Threonine Kinases , Administration, Topical , Animals , Apoptosis/drug effects , Brain Ischemia/etiology , Brain Ischemia/metabolism , Brain Ischemia/pathology , Caspase 3 , Caspase 9 , Caspases/drug effects , Caspases/metabolism , Cell Survival/drug effects , Enzyme Activation/drug effects , Glial Cell Line-Derived Neurotrophic Factor , Immunohistochemistry , In Situ Nick-End Labeling , Infarction, Middle Cerebral Artery/complications , Male , Nerve Growth Factors/administration & dosage , Neuroprotective Agents/administration & dosage , Phosphorylation , Proto-Oncogene Proteins/drug effects , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-akt , Rats , Rats, Wistar , Time Factors
7.
Neurol Res ; 25(3): 275-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12739237

ABSTRACT

To achieve an efficient delivery targeting to post-ischemic cerebral vascular endothelium, PEG-liposome conjugated with transferrin (Tf) (Tf-PEG-liposome) was intravenously administered to the rats after 90 min of transient middle cerebral occlusion. The expression of Tf receptor (TfR) in the cerebral endothelium increased with a peak at 1 day after the reperfusion and returned to the control level by 6 days. The Tf-PEG fluorescence was marginally detectable in sham control brain, but remarkably increased with a peak at 2 days, showing about 70% of TfR positive vascular endothelium double-labeled with Tf-PEG. These results indicate that the Tf-PEG-liposome could be utilized as an efficient drug delivery tool to the brain after stroke.


Subject(s)
Blood-Brain Barrier , Endothelium, Vascular/metabolism , Transferrin/administration & dosage , Animals , Brain Ischemia/drug therapy , Brain Ischemia/metabolism , Infarction, Middle Cerebral Artery/metabolism , Liposomes , Male , Polyethylene Glycols/administration & dosage , Rats , Rats, Wistar , Receptors, Transferrin/biosynthesis , Telencephalon/blood supply , Transferrin/metabolism , Transferrin/pharmacokinetics
8.
Acta Neurochir Suppl ; 86: 187-9, 2003.
Article in English | MEDLINE | ID: mdl-14753432

ABSTRACT

Oligodendrocyte progenitor cells (OPCs) mature to oligodendrocyte and remyelinate axons. OPCs express neuron-glial antigen 2 (NG2) chondroitin sulfate proteoglycan. We stained NG2 to investigate the effect of aging on the OPCs after cerebral ischemia. NG2 positive cells were examined at 1, 3, 7 days after 90 min of transient middle cerebral artery occlusion in young and aged brains. The number of NG2 positive cells increased in the ischemic penumbra at 3 and 7 days after reperfusion. At 7 day, the number of NG2 positive cells was significantly greater in the young than the aged brains, and the processes of NG2 positive cells enlarged and were more highly branched in the young than the aged brains. These results suggest that the young brain shows a higher potential of proliferation and process branching of OPCs than the aged brain.


Subject(s)
Aging , Ischemic Attack, Transient/pathology , Oligodendroglia/pathology , Stem Cells/pathology , Animals , Antigens/metabolism , Ischemic Attack, Transient/metabolism , Male , Oligodendroglia/metabolism , Proteoglycans/metabolism , Rats , Rats, Wistar , Stem Cells/metabolism
9.
Acta Neurochir Suppl ; 86: 575-9, 2003.
Article in English | MEDLINE | ID: mdl-14753509

ABSTRACT

The highly polysialylated neural cell adhesion molecule (PSA-NCAM) is involved in migration of neural stem cells as well as in neural plasticity. Immunoreactive PSA-NCAM expression was examined in rats with repeated exposure to amygdaloid kindled generalized seizures (GS). The number of PSA-NCAM positive cells in the bilateral dentate gyrus (DG) increased significantly from GS. Although the total number of positive cells was not significantly different between animals with 3 times GS (3 GS) and 30 times GS (30 GS), in the latter group a greater number of positive cells was observed in the outer granule cell layer (GCL) and a marked extension of immunopositive dendrites to the molecular layer. These observations indicate that increased migration of newly generated cells as well as plastic changes of preexisting neural cells occur in response to recurrent GS. This may contribute to an abnormal reconstruction of the synaptic network in the hippocampus and, thus, epileptogenicity from kindling.


Subject(s)
Hippocampus/physiopathology , Kindling, Neurologic , Neural Cell Adhesion Molecule L1/metabolism , Neurons/metabolism , Seizures/etiology , Seizures/physiopathology , Sialic Acids/metabolism , Animals , Cell Count , Cell Movement , Hippocampus/metabolism , Male , Neurons/pathology , Rats , Rats, Sprague-Dawley , Seizures/metabolism , Seizures/pathology
10.
Brain Res ; 958(2): 429-33, 2002 Dec 27.
Article in English | MEDLINE | ID: mdl-12470880

ABSTRACT

Glial cell line-derived neurotrophic factor (GDNF) activates protein kinase Akt/PKB by phosphorylation (p-Akt) which plays key roles in cell survival. In the current study, we investigated a temporal expression of p-Akt by immunohistochemical analysis after a topical application of GDNF to normal cerebral hemisphere of rats. Although p-Akt immunoreactivity was weakly present in the sham control neural cells, GDNF application greatly enhanced it at 3 h, which lasted until 1 day. These results indicate that p-Akt is expressed in neuronal cells under physiological conditions, and that topical application of GDNF greatly enhanced the phosphorylation of Akt in normal rat brain.


Subject(s)
Brain/enzymology , Brain/physiology , Nerve Growth Factors/pharmacology , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins , Signal Transduction/physiology , Animals , Brain/drug effects , Cell Survival/drug effects , Cell Survival/physiology , Glial Cell Line-Derived Neurotrophic Factor , Male , Nerve Growth Factors/administration & dosage , Neurons/drug effects , Neurons/enzymology , Protein Serine-Threonine Kinases/biosynthesis , Protein Serine-Threonine Kinases/physiology , Proto-Oncogene Proteins c-akt , Rats , Rats, Wistar , Signal Transduction/drug effects
11.
Brain Res ; 954(2): 317-22, 2002 Nov 08.
Article in English | MEDLINE | ID: mdl-12414116

ABSTRACT

A phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) is a tumor suppressor gene that suppresses cell growth, inhibits cell migration, and induces apoptosis. Phosphorylated form of PTEN (p-PTEN) is a key survival factor relating PI3K-Akt pathway and their downstream effectors. A spatiotemporal profiles of PTEN and p-PTEN expression were immunohistochemically examined after 90 min of transient middle cerebral artery occlusion in rats. In the ischemic core, PTEN progressively decreased by 3 days, whereas a rapid but transient increase of p-PTEN was found with a peak at 1 h after the reperfusion. In contrast, in the ischemic penumbra, PTEN showed a minor change and a gradual but sustained p-PTEN expression was observed in the ischemic penumbra with a peak at 12 h. In addition, the balance of population among strongly, moderately, and weakly stained cells was different between the ischemic core and penumbra at their peak time points. These results suggest an important role of p-PTEN for cell survival after ischemia as an upstream regulator for PI3K-Akt.


Subject(s)
Brain Ischemia/metabolism , Brain/metabolism , Phosphoric Monoester Hydrolases/metabolism , Phosphorylation , Tumor Suppressor Proteins/metabolism , Animals , Cell Survival , Immunohistochemistry , Infarction, Middle Cerebral Artery , Male , PTEN Phosphohydrolase , Rats , Rats, Wistar , Time Factors
12.
Neurol Res ; 24(7): 719-24, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12392212

ABSTRACT

Electro-acupuncture (EA) is an effective curative method for various diseases in oriental medicine. To investigate a detailed molecular mechanism of EA stimulation, an induction of phospho-Akt (p-Akt) was examined in normal adult rat brain after 60 min of EA with acupoints of Baihui (D20) and Renzhong (D26). In the sham control brain, strong neuronal p-Akt expression was found in ventral posterolateral thalamic nucleus (VPL) and medial habenular nuclei (MHb), but moderate to weak in cortex, caudate, CA1 sector and dentate gyrus of hippocampus, and ventral posteromedial thalamic nucleus. EA stimulation generally enhanced and sustained p-Akt expression for at least 24 h especially in the regions listed above, except VPL and MHb where no apparent change was found. Western blot analysis of p-Akt confirmed the enhanced signal intensity after EA at 8 and 24 h. These results suggest that the EA on D20 and D26 acupoints activates the survival Akt signal pathway, which may be maintaining the neural functions such as cell survival and memory formation in normal brain.


Subject(s)
Brain/metabolism , Electroacupuncture , Neurons/metabolism , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/metabolism , Up-Regulation/physiology , Animals , Brain/cytology , Cell Survival/physiology , Immunohistochemistry , Male , Nerve Growth Factors/metabolism , Neurons/cytology , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt , Rats , Rats, Wistar , Signal Transduction/physiology , Treatment Outcome
13.
Brain Res ; 935(1-2): 124-8, 2002 May 10.
Article in English | MEDLINE | ID: mdl-12062482

ABSTRACT

Expressions of immunophilin FKBP-12 and FKBP-52 were examined in the spinal cord of transgenic mice with an ALS-linked mutant Cu/Zn superoxide dismutase (SOD1) gene. The immunoreactivity of FKBP-12 was present predominantly in the cytoplasm, but did not show a difference between age-matched wild type and transgenic (Tg) mice at 25 and 35 weeks. In contrast, the immunoreactivity of FKBP-52 was predominantly present in the nucleus, which progressively declined only in the Tg mice as early as an early presymptomatic stage at 25 weeks of age in the anterior horn neurons. The present result suggests that the downregulation of FKBP-52 may be involved in the pathogenesis in the early stages of amyotrophic lateral sclerosis (ALS).


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Down-Regulation/genetics , Motor Neurons/metabolism , Spinal Cord/metabolism , Superoxide Dismutase/deficiency , Tacrolimus Binding Protein 1A/metabolism , Tacrolimus Binding Proteins/metabolism , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Animals , Cell Compartmentation/genetics , Cell Nucleus/metabolism , Cell Nucleus/pathology , Cytoplasm/metabolism , Cytoplasm/pathology , Disease Models, Animal , Immunohistochemistry , Mice , Mice, Transgenic , Motor Neurons/pathology , Mutation/genetics , Spinal Cord/pathology , Spinal Cord/physiopathology , Superoxide Dismutase/genetics , Superoxide Dismutase-1 , Time Factors
14.
Neuroscience ; 105(3): 571-8, 2001.
Article in English | MEDLINE | ID: mdl-11516824

ABSTRACT

Recent studies have shown that cyclosporin A, a specific antagonist of calcineurin, a phosphatase, ameliorates neuronal cell death in the CA1 sector of the hippocampus after forebrain ischemia in animal models. The mechanism of this neuroprotective effect, however, has not yet been established. Brain-derived neurotrophic factor (BDNF), a member of the neurotrophins, is one of the potent survival and developmental factors whose expression is regulated by cyclic AMP-response element-binding protein (CREB). Activation of CREB is dependent on its phosphorylation at Ser(133), and calcineurin has been reported to dephosphorylate CREB via protein phosphatase 1. Based on these observations, we attempted to investigate how cyclosporin A treatment would affect the changes of phosphorylated CREB (pCREB), BDNF and its receptor tyrosine kinase B (TrkB) after forebrain ischemia in rats. Phosphorylation of CREB was kept augmented throughout the time course examined in cyclosporin A-treated animals, while it ceased without cyclosporin A. Reverse transcription-polymerase chain reaction revealed prolonged maintenance of BDNF mRNA expression in the CA1 sector of cyclosporin A-treated animals. The protein expression of BDNF and TrkB appeared to be up-regulated in cyclosporin A-treated animals, whereas it was transiently up-regulated but decreased to the marginal level of expression without cyclosporin A.From these results we suggest that cyclosporin A induces pCREB by an inhibition of calcineurin, resulting in the induction of BDNF. The mechanisms by which cyclosporin A protects the CA1 region from neuronal cell death in forebrain ischemia may involve the interaction of pCREB, BDNF and TrkB.


Subject(s)
Brain Ischemia/drug therapy , Brain-Derived Neurotrophic Factor/drug effects , Cyclosporine/pharmacology , Enzyme Inhibitors/pharmacology , Neuroprotective Agents/pharmacology , Receptor, trkB/drug effects , Up-Regulation/drug effects , Animals , Blotting, Western , Brain Ischemia/metabolism , Brain Ischemia/physiopathology , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Cyclic AMP Response Element-Binding Protein/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , Hippocampus/drug effects , Hippocampus/pathology , Hippocampus/physiopathology , Immunohistochemistry , Male , Nerve Degeneration/drug therapy , Nerve Degeneration/physiopathology , Nerve Degeneration/prevention & control , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Phosphorylation/drug effects , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptor, trkB/metabolism , Transcription, Genetic/drug effects , Transcription, Genetic/physiology , Up-Regulation/physiology
15.
Brain Res ; 903(1-2): 162-7, 2001 Jun 08.
Article in English | MEDLINE | ID: mdl-11382399

ABSTRACT

We investigated the role of midbrain periaqueductal gray matter (PAG) in the manifestation of generalized seizures by administering electrical stimulation to this area in rats. Electrical stimulation of 60 Hz biphasic square pulses of a 1-s duration administered to the PAG-induced convulsive responses in the following order: (1) Type I, running (stimulus intensity; range 50--200 microA, mean 73.1 microA) without afterdischarge (AD), (2) Type IIa, running (stimulus intensity; range 50--300 microA, mean 111.8 microA) with AD at the PAG and the amygdala (AMY), and (3) Type IIb, generalized tonic--clonic seizures (GTCS) (stimulus intensity; range 50--250 microA, mean 182.1 microA) with AD at the PAG and AMY. Twenty daily PAG stimulations at the non-GTCS inducing threshold failed to produce kindling. However, 20 daily PAG stimulations at the GTCS threshold produced progressive AD spread involving the motor cortex, and progressive changes in the behavioral seizure pattern. These findings indicate that the PAG can be effectively kindled. However, PAG kindling has no apparent influence on subsequent AMY kindling.


Subject(s)
Kindling, Neurologic/physiology , Periaqueductal Gray/physiology , Amygdala/physiology , Animals , Electric Stimulation , Epilepsy, Tonic-Clonic/physiopathology , Male , Rats , Rats, Sprague-Dawley
17.
Endocr J ; 48(6): 665-9, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11873864

ABSTRACT

Standard therapy for ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH), a rare form of Cushing's syndrome, is bilateral adrenalectomy. Patients with AIMAH are usually elderly, with a variety of complications, and at risk for surgery. Postoperatively, they must receive lifelong corticosteroids and spend the remainder of their lives avoiding adrenal crisis. Therapy using metyrapone, a potent inhibitor of steroidogenesis, provides the advantages of avoiding the surgery. Its effectiveness is further anticipated because adrenal steroidogenic enzymes are reportedly weak in AIMAH. Treatment with metyrapone thus appears a good therapy for AIMAH, but its effectiveness has not, to our knowledge, been studied. We treated a 59-year-old man with AIMAH with metyrapone. At a low dose of metyrapone (500 to 750 mg/day), his plasma cortisol levels decreased to the normal range, and hypertension and diabetes mellitus were ameliorated. Therapy using metyrapone thus appears effective in treating AIMAH, and can be recommended for high risk AIMAH patients as an alternative therapy.


Subject(s)
Adrenal Glands/pathology , Cushing Syndrome/drug therapy , Enzyme Inhibitors/therapeutic use , Metyrapone/therapeutic use , Diabetes Mellitus, Type 2/complications , Enzyme Inhibitors/administration & dosage , Humans , Hydrocortisone/blood , Hyperplasia/complications , Hyperplasia/drug therapy , Hypertension/complications , Male , Metyrapone/administration & dosage , Middle Aged
18.
Brain Res ; 881(2): 152-8, 2000 Oct 27.
Article in English | MEDLINE | ID: mdl-11036153

ABSTRACT

Effects of microinjections of a single 2 or 10 nmol dose of N-methyl-D-aspartate (NMDA) into the unilateral mesencephalic reticular formation (MRF) on behavior and electroencephalogram were examined in rats (n=18) during a 15 min period (Exp. 1), and subsequent effects of sound stimulation with key jingling applied at 15, 30, and 45 min after the injections were observed (Exp. 2). The microinjections of 2 nmol dose of NMDA (n=10) induced hyperactivity (9 of 10 rats) and running/circling (8 of 10 rats) in Exp. 1, and hyperactivity (3 of 10 rats) in Exp. 2. Moreover, the microinjections of 10 nmol dose of NMDA (n=8) induced not only hyperactivity (8 of 8 rats) and running/circling (7 of 8 rats) but also generalized tonic-clonic seizures (GTCS) (5 of 8 rats) in Exp. 1; these seizure patterns were also elicited by sound stimulation in Exp. 2. The seizure patterns were accompanied by electroencephalographic seizure discharges in the MRF and the motor cortex. In contrast, the control group rats (n=10) which received a single dose of saline microinjection into the unilateral MRF showed no behavioral or electroencephalographic changes in both Exp. 1 and 2. These findings suggest that the MRF has an important role in the development of GTCS, which follows hyperactivity and running/circling, and that potentiation of excitatory neurotransmission in the MRF participates in the development of audiogenic seizures as well as GTCS.


Subject(s)
Acoustic Stimulation , Electroencephalography , Hyperkinesis/physiopathology , Mesencephalon/physiology , Reticular Formation/physiology , Seizures/physiopathology , Acoustic Stimulation/adverse effects , Animals , Excitatory Amino Acid Agonists , Hyperkinesis/chemically induced , Male , Microinjections , N-Methylaspartate , Rats , Rats, Sprague-Dawley , Seizures/chemically induced
19.
Carcinogenesis ; 20(5): 817-24, 1999 May.
Article in English | MEDLINE | ID: mdl-10334199

ABSTRACT

Fumonisin B1 (FB1) is a carcinogenic mycotoxin produced by the fungus Fusarium moniliforme in corn. Feeding of FB1 to rats causes acute liver injury, chronic liver injury progressing to cirrhosis, and sometimes terminates in hepatocellular carcinoma or cholangiocarcinoma. This study describes the histolopathology and changes in gene expression in the rat liver during short-term feeding of FB1. Male Fischer rats were fed either FB1 250 mg/kg or control diet, and were killed weekly for 5 weeks. FB1 caused a predominantly zone 3 'toxic' liver injury, with hepatocyte death due to necrosis and apoptosis. Hepatocyte injury and death were mirrored by hepatic stellate cell proliferation and marked fibrosis, with progressive disturbance of architecture and formation of regenerative nodules. Despite ongoing hepatocyte mitotic activity, oval cell proliferation was noted from week 2, glutathione S-transferase pi-positive hepatic foci and nodules developed and, at later time points, oval cells were noted inside some of the 'atypical' nodules. Northern blot (mRNA) analysis of liver specimens from weeks 3 to 5 showed a progressive increase in gene expression for alpha-fetoprotein, hepatocyte growth factor, transforming growth factor alpha (TGF-alpha) and especially TGF-beta1 and c-myc. Immunostaining with LC(1-30) antibody demonstrated a progressive increase in expression of mature TGF-beta1 protein by hepatocytes over the 5 week feeding period. The overexpression of TGF-beta1 may be causally related to the prominent apoptosis and fibrosis seen with FB1-induced liver injury. Increased expression of c-myc may be involved in the cancer promoting effects of FB1.


Subject(s)
Carboxylic Acids/adverse effects , Carcinogens, Environmental/adverse effects , Fumonisins , Fusarium/chemistry , Liver/drug effects , Animals , Carboxylic Acids/administration & dosage , Carcinogens, Environmental/administration & dosage , Desmin/analysis , Diet , Gene Expression/drug effects , Glutathione S-Transferase pi , Glutathione Transferase/analysis , Hepatocyte Growth Factor/genetics , Immunohistochemistry , Isoenzymes/analysis , Liver/metabolism , Liver/pathology , Male , Mycotoxins/administration & dosage , Mycotoxins/adverse effects , Proto-Oncogene Proteins c-myc/genetics , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , Transforming Growth Factor alpha/genetics , Transforming Growth Factor beta/analysis , Transforming Growth Factor beta/genetics , alpha-Fetoproteins/genetics
20.
J Periodontal Res ; 34(6): 290-5, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10633883

ABSTRACT

The cytocidal effects of tetracyclines and fluoroquinolones on human periodontal ligament fibroblasts (Pel cells) were studied. Pel cells were treated for 24 h with tetracycline (TC), demeclocycline (DMC), minocycline (MINO), chlortetracycline (CTC), tosufloxacin (TFLX), enoxacin (ENX), sparfloxacin (SPFX), lomefloxacin (LFLX) or ofloxacin (OFLX), and allowed to form colonies. The cytocidal effects of the antibacterial agents, as determined by a decrease in colony-forming efficiency, increased as the dose increased. However, CTC was an exception. As a quantitative measure of the cytocidal effect, LD50, the concentration which results in a 50% decrease in colony-forming efficiency relative to control cells, was extrapolated from the dose-response curves. The rank-order of cytocidal effects (LD50) was DMC [symbol: see text] MINO [symbol: see text] TC >> CTC. DMC, MINO and TC were at least 5.6-6.6 times more cytocidal than CTC. The cytocidal effects of the fluoroquinolones were in the following order: TFLX > ENX > SPFX > LFLX > OFLX. TFLX, ENX, SPFX and LFLX were 36.3, 11.4, 7.7 and 3.1 times more cytocidal than OFLX, respectively. Little cytocidal effect was observed when the cells were treated with either < or = 0.03 mM tetracyclines or < or = 0.01 mM fluoroquinolones. The results provide useful estimates concerning the relative toxicities against human periodontal ligament of antibacterial agents used to treat periodontitis.


Subject(s)
Anti-Infective Agents/toxicity , Periodontal Ligament/drug effects , Tetracyclines/toxicity , Alkaline Phosphatase/drug effects , Cell Culture Techniques/methods , Cell Death/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/enzymology , Fluoroquinolones , Humans , Lethal Dose 50 , Periodontal Ligament/cytology , Periodontal Ligament/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL